Incidence of EPSE was higher in the risperidone group but did not reach statistical significance when compared to placebo, with a relative risk (RR) of 1.4 and confidence interval (CI) of 0.93–2.1.
← all excerpts
Clinical utility of the risperidone formulations in the management of schizophrenia.
1
—
—